Dopaminergic neurotoxicity of HIV-1 gp120: Reactive oxygen species as signaling intermediates
Authors:
- Jean-Pierre LouboutinJLJean-Pierre Louboutin
- Elena MarusichEMElena Marusich
- Beverley A.S. ReyesBRBeverley A.S. Reyes
- Elisabeth J. Van BockstaeleEBElisabeth J. Van Bockstaele
- David S. StrayerDSDavid S. Strayer
- 1 January 2010
- journal article
- Published by Elsevier in Brain Research
- Vol. 1306, 116-130
Abstract
No abstract availableKeywords
Funding Information
- NIH (MH70287)
This publication has 70 references indexed in Scilit:
- Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradationJournal of Clinical Investigation, 2009
- Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final stepsApoptosis, 2009
- Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosisOncogene, 2008
- Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuseNeuroImage, 2008
- Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stressNeuroscience Letters, 2008
- Consequences of impaired purine recycling in dopaminergic neuronsNeuroscience, 2008
- Neurotoxicity of HIV-1 Tat protein: Involvement of D1 dopamine receptor☆NeuroToxicology, 2007
- Hydrogen Peroxide: A Signaling MessengerAntioxidants & Redox Signaling, 2006
- The neuropathogenesis of AIDSNature Reviews Immunology, 2005
- Chemical neuroanatomy of the basal ganglia — normal and in Parkinson's diseaseJournal of Chemical Neuroanatomy, 2001